Conspectus
Natural products are biosynthesized from
a limited pool of starting
materials via pathways that obey the same chemical logic as textbook
organic reactions. Given the structure of a natural product, it is
therefore often possible to predict its likely biosynthesis. Although
biosynthesis mainly occurs in the highly specific chemical environments
of enzymes, the field of biomimetic total synthesis attempts to replicate
predisposed pathways using chemical reagents.
We have followed
several guidelines in our biomimetic approach
to total synthesis. The overarching aim is to construct the same skeletal
C–C and C–heteroatom bonds and in the same order as
our biosynthetic hypothesis. In order to explore the innate reactivity
of (bio)synthetic intermediates, the use of protecting groups
is avoided or at least minimized. The key step, which is usually a
cascade reaction, should be predisposed to selectively generate molecular
complexity under substrate control (e.g., cycloadditions, radical
cyclizations, carbocation rearrangements). In general, simple reagents
and mild conditions are used; many of the total syntheses presented
in this Account could be achieved using pre-1980s methodology. We
have focused almost exclusively on the synthesis of meroterpenoids,
that is, natural products of mixed terpene and aromatic polyketide
origin, using commercially available terpenes and electron-rich aromatic
compounds as starting materials. Finally, all of the syntheses in
this Account involve a dearomatization step as a means to trigger
a cascade reaction or to construct stereochemical complexity from
a planar, aromatic intermediate.
A biomimetic strategy can offer
several advantages to a total synthesis
project. Most obviously, successful biomimetic syntheses are usually
concise and efficient, naturally adhering to the atom, step, and redox
economies of synthesis. For example, in this Account, we describe
a four-step synthesis of garcibracteatone and a three-step synthesis
of nyingchinoid A. It is difficult to imagine shorter, non-biomimetic
syntheses of these intricate molecules. Furthermore, biomimetic synthesis
gives insight into biosynthesis by revealing the chemical relationships
between biosynthetic intermediates. Access to these natural substrates
allows collaboration with biochemists to help uncover the function
of newly discovered enzymes and elucidate biosynthetic pathways, as
demonstrated in our work on the napyradiomycin family. Third, by making
biosynthetic connections between natural products, we can sometimes
highlight incorrect structural assignments, and herein we discuss
structure revisions of siphonodictyal B, rasumatranin D, and furoerioaustralasine.
Last, biomimetic synthesis motivates the prediction of “undiscovered
natural products” (i.e., missing links in biosynthesis), which
inspired the isolation of prenylbruceol A and isobruceol.